Anne M. Plomgaard

Hvidovre, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical Trial.

Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical Trial.

Journal: JAMA pediatrics
Published: April 20, 2026

Respiratory morbidity in newborns with a gestational age at or above 32 weeks.

Respiratory morbidity in newborns with a gestational age at or above 32 weeks.

Journal: Danish medical journal
Published: March 24, 2025

Cerebral oximetry monitoring versus usual care for extremely preterm infants: a detailed statistical analysis plan for the 2-year follow-up of the participants of the SafeBoosC-III randomised clinical trial.

Cerebral oximetry monitoring versus usual care for extremely preterm infants: a detailed statistical analysis plan for the 2-year follow-up of the participants of the SafeBoosC-III randomised clinical trial.

Journal: Trials
Published: October 25, 2024

Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial.

Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial.

Journal: Trials
Published: June 04, 2023

Early EEG-burst sharpness and 2-year disability in extremely preterm infants.

Early EEG-burst sharpness and 2-year disability in extremely preterm infants.

Journal: Pediatric research
Published: June 24, 2022

Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial.

Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial.

Journal: PloS one
Published: September 01, 2020

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.

Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: January 31, 2018

Structural brain maturation differs between preterm and term piglets, whereas brain activity does not.

Structural brain maturation differs between preterm and term piglets, whereas brain activity does not.

Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: June 21, 2017

Prognostic Accuracy of Electroencephalograms in Preterm Infants: A Systematic Review.

Prognostic Accuracy of Electroencephalograms in Preterm Infants: A Systematic Review.

Journal: Pediatrics
Published: November 08, 2016

Cerebral oximetry in preterm infants: an agenda for research with a clear clinical goal.

Cerebral oximetry in preterm infants: an agenda for research with a clear clinical goal.

Journal: Neurophotonics
Published: March 18, 2016

Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.

Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.

Journal: PloS one
Published: February 22, 2016

The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.

The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.

Journal: Pediatric research
Published: June 17, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026